# BRSK1

## Overview
BRSK1, or brain-specific kinase 1, is a gene that encodes a serine/threonine kinase protein predominantly expressed in the brain. The protein, also referred to as BR serine/threonine kinase 1, plays a pivotal role in neuronal development and function, particularly in establishing neuronal polarity and synaptic organization. BRSK1 is activated through phosphorylation by LKB1, which is essential for its enzymatic activity. The protein is characterized by its N-terminal serine/threonine kinase domain and a ubiquitin-associated domain, which contribute to its regulatory functions. BRSK1's activity is modulated by post-translational modifications such as phosphorylation and palmitoylation, which influence its localization to lipid rafts and its interaction with other synaptic proteins. These modifications are crucial for its role in axon growth and neurotransmitter release. Additionally, BRSK1 is involved in redox regulation, which affects its catalytic activity through oxidative modifications (Bendzunas2023Redox; RodríguezAsiain2011Brain).

## Structure
BRSK1, also known as brain-specific kinase 1, is a protein kinase with a distinct molecular structure. It features an N-terminal serine/threonine kinase domain, spanning residues 34-285, which is crucial for its enzymatic activity (RodríguezAsiain2011Brain). The protein also contains a ubiquitin-associated (UBA) domain between residues 330-372, which is involved in autoregulation and potentially interacts with polyubiquitin (Marx2010Structure). The C-terminal region, extending from residues 373-778, has an unknown structure and function (RodríguezAsiain2011Brain).

BRSK1 undergoes several post-translational modifications, including phosphorylation and palmitoylation. Phosphorylation at threonine 189 by LKB1 is essential for its activation, with mutations at this site affecting its activity (RodríguezAsiain2011Brain). Palmitoylation, the covalent attachment of a palmitate group, increases the protein's hydrophobicity and is confirmed using the acyl-biotin exchange assay (RodríguezAsiain2011Brain). This modification may target BRSK1 to lipid rafts, influencing its synaptic function (RodríguezAsiain2011Brain).

The protein's redox regulation involves cysteine residues forming intramolecular disulfide bonds, which modulate its activity (Bendzunas2023Redox). BRSK1 does not have apparent lipid-binding domains or transmembrane hydrophobic α-helices, yet it associates with lipid rafts, likely due to palmitoylation (RodríguezAsiain2011Brain). The presence of splice variant isoforms is suggested by a double band pattern in western blot assays, possibly due to alternative splicing (RodríguezAsiain2011Brain).

## Function
BRSK1, also known as brain-specific kinase 1, is a serine-threonine kinase predominantly expressed in the brain, where it plays a crucial role in neuronal development and function. It is involved in establishing neuronal polarity, a key process for axon-dendrite specification, and is essential for proper synaptic function (Bright2008Investigating; RodríguezAsiain2011Brain). BRSK1 is activated by LKB1-mediated phosphorylation at a threonine residue in its T-loop, specifically Thr189, which is necessary for its activation (Bright2008Investigating; RodríguezAsiain2011Brain).

BRSK1 localizes to lipid rafts within the cell membrane, where its activity is enhanced. This localization is facilitated by palmitoylation, a posttranslational modification that targets BRSK1 to these microdomains. The lipid raft environment enhances BRSK1's kinase activity, potentially by protecting it from dephosphorylation or by the absence of inactivating phosphatases (RodríguezAsiain2011Brain). BRSK1 phosphorylates microtubule-associated protein Tau and cell-cycle checkpoint kinase Wee1, which are essential for axon growth and neuronal polarity (RodríguezAsiain2011Brain). Its activity is also modulated by redox regulation, involving reversible oxidative modifications of cysteine residues (Bendzunas2023Redox).

## Clinical Significance
Mutations and alterations in the BRSK1 gene have been associated with several clinical conditions, particularly in the context of reproductive health and cancer. BRSK1 is linked to early menopause, as mutations in this gene can disrupt the release of gonadotropin-releasing hormone, which is crucial for reproductive function. This disruption affects the hypothalamic-pituitary-ovarian axis, potentially leading to early menopause (Fu2019Genetic; Thasneem2022Genes). Specific single nucleotide polymorphisms (SNPs) in BRSK1, such as rs1172822, have been significantly associated with the age at natural menopause onset in various populations, including European, Chinese, and Caucasian groups (Fu2019Genetic).

In the realm of oncology, BRSK1 expression levels have been correlated with survival outcomes in breast cancer. High expression of BRSK1 is associated with improved prognosis in TP53-mutant breast cancer, suggesting its potential role as a prognostic marker (Zhao2020Identification). Additionally, BRSK1 is linked to increased survival in several breast cancer subtypes, including Luminal A, Luminal B, HER2-enriched, and Basal-like breast cancers (Khoa2021Evaluation). These findings highlight the gene's significance in both reproductive and cancer-related clinical contexts.

## Interactions
BRSK1, a serine/threonine kinase, is involved in various interactions that influence its function and regulation. It is activated by LKB1-mediated phosphorylation, which is crucial for its role in establishing neuronal polarity and regulating neurotransmitter release presynaptically (RodríguezAsiain2011Brain). BRSK1 interacts with synaptic vesicle proteins such as Synaptophysin and Bassoon, indicating its involvement in synaptic organization and neurotransmitter release (Ramírez2018Neuronal). 

BRSK1 is associated with lipid rafts, which are cholesterol- and sphingolipid-rich microdomains in the cell membrane. This association is modulated by palmitoylation, a posttranslational modification that targets proteins to these rafts, enhancing BRSK1's kinase activity by protecting it from dephosphorylation (RodríguezAsiain2011Brain). Although BRSK1 does not bind major lipids or phospholipids present in raft microdomains, it binds to the galactocerebroside sulfatide, although this is not believed to be involved in its localization to lipid rafts (RodríguezAsiain2011Brain).

The redox regulation of BRSK1 involves oxidative modifications of conserved cysteine residues, which can form intramolecular disulfide bonds, affecting its catalytic activity and interactions (Bendzunas2023Redox). However, specific physical interactions of BRSK1 with other proteins or nucleic acids are not detailed in the provided context.


## References


1. (Bendzunas2023Redox) Redox Regulation of Brain Selective Kinases BRSK1/2: Implications for Dynamic Control of the Eukaryotic AMPK family through Cys-based mechanisms. This article has 1 citations.

[2. (Ramírez2018Neuronal) Leticia Ramírez Martínez, Miguel Vargas Mejía, Josep Espadamala, Néstor Gomez, José M. Lizcano, and Esther López-Bayghen. Neuronal growth factor regulates brain specific kinase 1 expression by inhibiting promoter methylation and promoting sp1 recruitment. Neurochemistry International, 120:213–223, November 2018. URL: http://dx.doi.org/10.1016/j.neuint.2018.08.014, doi:10.1016/j.neuint.2018.08.014. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.neuint.2018.08.014)

[3. (Thasneem2022Genes) Kamila Thasneem, Iyshwarya Bhaskar Kalarani, Prema Jayaprasad, Vajagathali Mohammed, and Ramakrishnan Veerabathiran. Genes linked with early menopause and the pathogenesis of its associated diseases: a systematic review. Middle East Fertility Society Journal, January 2022. URL: http://dx.doi.org/10.1186/s43043-021-00093-0, doi:10.1186/s43043-021-00093-0. This article has 3 citations.](https://doi.org/10.1186/s43043-021-00093-0)

[4. (Bright2008Investigating) Nicola J. Bright, David Carling, and Claire Thornton. Investigating the regulation of brain-specific kinases 1 and 2 by phosphorylation. Journal of Biological Chemistry, 283(22):14946–14954, May 2008. URL: http://dx.doi.org/10.1074/jbc.m710381200, doi:10.1074/jbc.m710381200. This article has 50 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.m710381200)

[5. (Marx2010Structure) A. Marx, C. Nugoor, S. Panneerselvam, and E. Mandelkow. Structure and function of polarity‐inducing kinase family mark/par‐1 within the branch of ampk/snf1‐related kinases. The FASEB Journal, 24(6):1637–1648, January 2010. URL: http://dx.doi.org/10.1096/fj.09-148064, doi:10.1096/fj.09-148064. This article has 105 citations.](https://doi.org/10.1096/fj.09-148064)

[6. (Fu2019Genetic) Xiaoyi Fu, Hongyan Wang, and Xiaojin Zhang. Genetic aspects of early menopause. Journal of Bio-X Research, 02(03):105–111, September 2019. URL: http://dx.doi.org/10.1097/JBR.0000000000000043, doi:10.1097/jbr.0000000000000043. This article has 13 citations.](https://doi.org/10.1097/JBR.0000000000000043)

[7. (Zhao2020Identification) Feng Zhao, Peibin Wang, Yan Guo, Qi Lu, Xu Kong, Dongwei Su, Hengyu Li, Guoping Liu, and Chaoqian Liu. Identification of the potential roles of ring finger protein 8 in tp53‑mutant breast cancer. Oncology Letters, 21(1):1–1, November 2020. URL: http://dx.doi.org/10.3892/ol.2020.12303, doi:10.3892/ol.2020.12303. This article has 8 citations and is from a peer-reviewed journal.](https://doi.org/10.3892/ol.2020.12303)

[8. (RodríguezAsiain2011Brain) Arantza Rodríguez-Asiain, Gerard Ruiz-Babot, Walter Romero, Roger Cubí, Tatiana Erazo, Ricardo M. Biondi, Jose R. Bayascas, Jose Aguilera, Nestor Gómez, Carles Gil, Enrique Claro, and Jose M. Lizcano. Brain specific kinase-1 brsk1/sad-b associates with lipid rafts: modulation of kinase activity by lipid environment. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 1811(12):1124–1135, December 2011. URL: http://dx.doi.org/10.1016/j.bbalip.2011.10.004, doi:10.1016/j.bbalip.2011.10.004. This article has 21 citations.](https://doi.org/10.1016/j.bbalip.2011.10.004)

[9. (Khoa2021Evaluation) Nguyen Khoa, Rivera Andrew, Alzoubi Madlin, Wathieu Henri, Dong Shengli, Yousefi Hassan, Matossian Margarite, Alahari Suresh, Drewry David, Burow Matthew, and Collins-Burow Bridgette. Evaluation of liver kinase b1 downstream signaling expression in various breast cancers and relapse free survival after systemic chemotherapy treatment. Oncotarget, 12(11):1110–1115, May 2021. URL: http://dx.doi.org/10.18632/oncotarget.27929, doi:10.18632/oncotarget.27929. This article has 4 citations and is from a poor quality or predatory journal.](https://doi.org/10.18632/oncotarget.27929)